Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1974-03-15
1978-06-06
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
536 27, 536 28, 536 29, A61K 3152, C07H 1920, A61K 3170
Patent
active
040937143
ABSTRACT:
9-.beta.-D-Arabinofuranosyl nucleotides of the following structure are disclosed: ##STR1## wherein AP is a 3' or 5' phosphorylated arabinofuranoside or the corresponding 3', 5' cyclic phosphate joined by a glycoside linkage to N.sup.9 of the aglycon component of said nucleotide, and Z is H, C.sub.1 -C.sub.6 alkyl, C.sub.7 -C.sub.10 aralkoxy, or hydroxy.
Compounds prepared according to the invention exhibit antiviral activity in vitro, while others are precursors useful in the synthesis of bioactive compounds.
REFERENCES:
patent: 3049536 (1962-08-01), Reiff et al.
patent: 3170917 (1965-02-01), Laufer et al.
patent: 3300478 (1967-01-01), Wechter
patent: 3314938 (1967-04-01), Kawashima et al.
patent: 3317512 (1967-05-01), Wechter
patent: 3328389 (1967-06-01), Shimizu et al.
patent: 3337530 (1967-08-01), Hanze
patent: 3728329 (1973-04-01), Yano et al.
patent: 3755296 (1973-08-01), Kanai et al.
Revankar Ganapathi R.
Sidwell Robert W.
Tolman Richard L.
Boswell K. H.
Brown Johnnie R.
ICN Pharmaceuticals, Inc.
LandOfFree
9.beta.-D-Arabinofuranosylpurine nucleotides and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 9.beta.-D-Arabinofuranosylpurine nucleotides and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9.beta.-D-Arabinofuranosylpurine nucleotides and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1493301